Edanz 20120313 pres2_print


Published on

Published in: Health & Medicine, Technology
  • Be the first to comment

  • Be the first to like this

No Downloads
Total views
On SlideShare
From Embeds
Number of Embeds
Embeds 0
No embeds

No notes for slide

Edanz 20120313 pres2_print

  1. 1. Preparing for Publication Improving your ImpactOsaka Prefecture UniversityAmanda HindleSenior Language EditorEdanz Group Japan13 March 2012
  2. 2. What do journal editors and reviewers want? Is the manuscript sufficiently novel? Is the manuscript of broad enough interest? Are the findings significant? Will they haveimpact? Novelty Aims and Scope Significance Impact Factor Edanz Group Japan | 2
  3. 3. Evaluating significance: importance Specific interest only or of interest to many Affect many (e.g. new tool) Support for (or contradiction of) an existing theory Substantially improve our understanding of a phenomenon or provide a new technology or disease treatment? Edanz Group Japan | 3
  4. 4. Evaluating significance: novelty How novel are my results compared with those already published? New findings Incremental Conceptual advances advances Low to medium Medium to high impact factor impact factor Edanz Group Japan | 4
  5. 5. Evaluating significance: relevance Specific to a geographical region or ethnic population? Results first of their kind? International significance? Edanz Group Japan | 5
  6. 6. Evaluating significance: appeal Does my research have ‘popular appeal’? Examples: Optogenetics Higgs boson Epigenetics Global warming Stem cells Clean tech Edanz Group Japan | 6
  7. 7. Enhancing significance Clearly communicating the significance of findings can increase the chances of acceptance in your target journal Clearly explain the rationale and aims Link back to these in the Discussion section Describe the most important finding first Follow with validating findings Edanz Group Japan | 7
  8. 8. Enhancing significanceImportance“Our results… suggest that left-right asymmetricepigenetic regulation can establish bilateralasymmetry in the nervous system.” Edanz Group Japan | 8
  9. 9. Enhancing significanceNovelty“We report the isolation of the first mutant histoneallele recovered from a genetic screen of amulticellular organism” Edanz Group Japan | 9
  10. 10. Enhancing significanceRelevance and Appeal“We suggest that... could be a conserved epigeneticmechanism that generates bilateral asymmetries inthe nervous system in organisms as distant asnematodes and mammals.” Edanz Group Japan | 10
  11. 11. Packaging results: to divide or not to divide Example In situ andGene expression Corresponding western blot analyses behavioural data validations Low to medium Low to medium impact factor impact factor Edanz Group Japan | 11
  12. 12. Packaging results: to divide or not to divide Example In situ andGene expression Corresponding western blot analyses behavioural data validations Medium to high impact factor Edanz Group Japan | 12
  13. 13. Increasing output Review article following pre- submission enquiry Commentaries Opinion pieces New method developed and novel findings obtained using it Follow-up paper(s) using method Methods paper Primary publication applied to other reporting main problems findings Edanz Group Japan | 13
  14. 14. Choosing a target journal: timing Before fully assembling the manuscript After the results to be published have been obtained After a decision has been made on how high to aim—high, medium or low impact After you have decided on the article type Edanz Group Japan | 14
  15. 15. Choosing a target journal: how Honestly evaluate the manuscript Check the stated aims and scope and impact factor of potential target journals Novelty Aims and Scope Significance Impact Factor Edanz Group Japan | 15
  16. 16. Choosing a target journal: how What journals have published similar findings What journals were the papers cited in your manuscript published in?Attribute/Preference Journal Name Journal Name Journal Name Journal NameAppropriate article type?Appropriate aims and scope/readership?Published related articles?Study meets all journal requirements?Appropriate impact factor?Meets other preferences e.g. open accessOverall decision Edanz Group Japan | 16
  17. 17. Choosing a target journal: howAttribute/Preference Clinical NeuropharmacologyAppropriate article type? Yes Case reportAppropriate aims and Clinical and experimental research, allscope/readership? Yes areas of pharmacology related to the CNS Schönfelder S, Schirmbeck F, Waltereit R, et al. AripiprazolePublished related articles? improves olanzapine-associated obsessive compulsive Yes symptoms in schizophrenia. Clin Neuropharmacol 2011;34(6):256–257Study meets all journal requirements? Yes Informed consent must be providedAppropriate impact factor? Yes 1.578Meets other preferences e.g. openaccess No Open access not offeredOverall decision 1st Most suitable initial target Edanz Group Japan | 17
  18. 18. Cover letters Competition for publication space and for editors’ attention is very high It may not be enough to send a cover letter to a journal editor like this:Dear Editor-in-Chief,I am sending you our manuscript entitled “Techniques to detect circoviruses in Japanesebird species” by Hindle et al. We would like to have the manuscript considered forpublication in Archives of Virology.Please let me know of your decision at your earliest convenience.Sincerely yours,Amanda Hindle Edanz Group Japan | 18
  19. 19. Your cover letter General rules Address to the editor personally Provide manuscript title and publication type Background, rationale, description of results Explain importance of your findings Why would they be of interest to the journal’s target audience? Provide corresponding author details Include any must-have statements Edanz Group Japan | 19
  20. 20. Cover letter ExampleDear Dr Lisberger,Please find enclosed our manuscript entitled “Amyloid-like inclusions in the brains of Huntington’s disease patients”, byMcGowan et al., which we would like to submit for publication as a Research Paper in Neuroscience.Recent immunohistochemical studies have revealed the presence of neuronal inclusions containing an N-terminal portion of Give thethe mutant huntingtin protein and ubiquitin in the brain tissues of Huntington’s disease (HD) patients; however, the role of background tothese inclusions in the disease process has remained unclear. One suspected disease-causing mechanism in Huntington’sdisease and other polyglutamine disorders is the potential for the mutant protein to undergo a conformational change to a the researchmore stable anti-parallel β-sheet structure…To confirm if the immunohistochemically observed huntingtin- and ubiquitin-containing inclusions display amyloid features, we What was doneperformed Congo red staining and both polarizing and confocal microscopy on post-mortem human brain tissues obtainedfrom five HD patients, two AD patients, and two normal controls. Congo red staining revealed a small number of amyloid-like and what wasinclusions showing green birefringence by polarized microscopy, in a variety of cortical regions.... ….detected inclusions foundobserved in parallel sections, suggesting that only a relatively small proportion of inclusions in HD adopt an amyloid-likestructure.We believe our findings would appeal to a broad audience, such as the readership of Neuroscience. As a wide-reaching journal Interest topublishing original research on all aspects of neuroscience… journal’s readersWe confirm that this manuscript has not been published elsewhere and is not under consideration by another journal. All Conforms toauthors have approved the manuscript and agree with submission to Neuroscience. We have read and have abided by the journalstatement of ethical standards for manuscripts submitted to Neuroscience. The authors have no conflicts of interest to declare. requirementsPlease address all correspondence to…. Edanz Group Japan | 20
  21. 21. Recommending reviewers“… the contact details (including email addresses) of at least four potential peerreviewers for your paper. These should be experts in your field of study, who will be ableto provide an objective assessment of the manuscripts quality. Any peer reviewers yousuggest should not have recently published with any of the authors of your manuscriptand should not be members of the same research institution.” From your reading and references Networking Aim for younger and mid-level scientists Provide a reason for recommending/excluding areviewer Editors have the final decision on reviewer choice Edanz Group Japan | 21
  22. 22. Communication Journals Polite and professional Query manuscript status Address to the appropriate person Be aware of processing timelines AVOID harassing journal editors Edanz Group Japan | 22
  23. 23. Reasons for rejection: the science Methods Validations Research question Statistics Data versus conclusions Edanz Group Japan | 23
  24. 24. Reasons for rejection: the manuscript Methods detail Citations Rationale and aims Results format Limitations Edanz Group Japan | 24
  25. 25. Reasons for rejection: other Inappropriate journal Inappropriate selected: scope, timing: too early or impact, audience late Edanz Group Japan | 25
  26. 26. Peer review Peer review exists to ensure that your paper is as scientifically robust and complete as possible An opportunity to improve your contribution, not an inconvenience Open / Blind / Double blind Edanz Group Japan | 26
  27. 27. Peer review Very few papers are Rejection Acceptance immediately accepted Minor revision without need for any Major revision revisions Free, expert advice Complete rejection Journal editor Major revisions decision Minor revisions Acceptance Edanz Group Japan | 27
  28. 28. Revision How to respond Politely respond to ALL the reviewers’ comments in a response letter Make it easy to see changes Use specific line, page and/or paragraph numbers Different color font Highlight the text Edanz Group Japan | 28
  29. 29. Revision How to respond Conduct the additional experiments suggested If this is impossible, you MUST explain why You can disagree with reviewers BUT provide evidence (cite references) Comply with deadlines Edanz Group Japan | 29
  30. 30. Your response letter The preambleDear Dr. _____________: [address the editor byname]Thank you for your consideration of our manuscriptentitled _____________ [insert manuscript titlehere]. We have reviewed the comments of thereviewers and have thoroughly revised themanuscript. We found the comments helpful, andbelieve our revised manuscript represents asignificant improvement over our initial submission.In response to the reviewers’ suggestions we have …[summarize the key changes here] Edanz Group Japan | 30
  31. 31. Point-by-point response AgreeingAfter the preamble, address every reviewer pointindividuallyReviewer Comment: In your analysis of the data you have chosen touse a somewhat obscure fitting function (regression). In my opinion,a simple Gaussian function would have sufficed. Moreover, theresults would be more instructive and easier to compare to previousresults.Response: We agree with the reviewer’s assessment of the analysis.Our tailored function makes it impossible to fully interpret the datain terms of the prevailing theories. In addition, in its current form itwould be difficult to tell that this measurement constitutes asignificant improvement over previously reported values. We havereanalyzed our data using a Gaussian fitting function. Edanz Group Japan | 31
  32. 32. Point-by-point response DisagreementSometimes you will disagree with the reviewer. Keepyour response polite and professionalReviewer Comment: In your analysis of the data you have chosento use a somewhat obscure fitting function (regression). In myopinion, a simple Gaussian function would have sufficed. Moreover,the results would be more instructive and easier to compare toprevious results.Response: We agree with the reviewer that a simple Gaussian fitwould facilitate comparison with the results of other studies.However, our tailored function allows for the analysis of the data interms of the Smith model [Smith et al, 1998]. We have added twosentences to the manuscript (page 3, line 4) to justify the use ofthis function and Smith’s model. Edanz Group Japan | 32
  33. 33. Understanding reviewer comments “The English needs to be improved” “Your writing is difficult to understand”GrammarLong, complex sentences and paragraphsNon-native expressionsGaps in the logicPoor organization of the manuscriptFlowToo much information Edanz Group Japan | 33
  34. 34. Understanding reviewer comments“The authors hypothesized to look for the pharmacokinetics ofthe insulin using this 4 mm needle; however, they didnt dobioequivalence analyses for glucose pharmacodynamics. That isone of my concerns about this methodology.” Questions from reviewers may not always be apparent Cosmetic changes Edanz Group Japan | 34
  35. 35. SummaryThink about the reader – make it easyThink from the journal’s perspectiveReviewer comments are free expert advice Edanz Group Japan | 35
  36. 36. Resources and links http://edanzediting.co.jp/osaka_201203 This presentation Templates Guidelines Edanz Group Japan | 36
  37. 37. Thank you! Edanz Group Japan | 37
  38. 38. Cover letters Common phrasesPlease find enclosed our manuscript entitled (title) by(First Author) et al., which we would like to submit forpublication as a (Publication Type) in (Journal name).To our knowledge, this is the first report showing…We believe our findings would appeal to the readershipof (Journal name).Please address all correspondence to:We shall look forward to hearing from you at yourearliest convenience. Edanz Group Japan | 38
  39. 39. Response Letter Common phrasesPlease find enclosed our revised manuscript entitled(title) by (First Author) et al., which we would like toresubmit for publication as a (Publication Type) in(Journal name).Your comments and those of the reviewers were veryhelpful.In the following pages are our point-by-point responsesto each of the comments of the reviewers. Edanz Group Japan | 39